Literature DB >> 21396480

Induction of apoptosis by 15d-PGJ2 via ROS formation: an alternative pathway without PPARγ activation in non-small cell lung carcinoma A549 cells.

Jun-Jie Wang1, Oi-Tong Mak.   

Abstract

Cyclopentenone prostaglandin 15-deoxy-Δ(12,14)-prostaglandin J(2) (15d-PGJ(2)), which is generated from the dehydration of PGD(2), is a natural ligand of peroxisome proliferator-activated receptor gamma (PPARγ) and a potential apoptotic mediator. The synthetic PPARγ ligands, troglitazone and ciglitazone, inhibit tumor progression in many cells by PPARγ activation, but the mechanism of 15d-PGJ(2) is still unclear. In this study, GW9662, an antagonist of PPARγ, and quercetin, a natural antioxidant, were used to study the apoptotic mechanism of 15d-PGJ(2) in A549 cells. Results showed that 15d-PGJ(2) induced apoptosis, which was associated with the production of reactive oxygen species (ROS) and the decrease of GSH levels. Furthermore, quercetin reduced the activity of caspases in 15d-PGJ(2)-induced apoptotic processes. These results suggest that 15d-PGJ(2) induces apoptosis in A549 cells mainly through the formation of ROS; it does not depend on PPARγ activation. Moreover, these findings support the use of quercetin and PPARγ agonists in non-small cell lung carcinoma.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21396480     DOI: 10.1016/j.prostaglandins.2011.01.004

Source DB:  PubMed          Journal:  Prostaglandins Other Lipid Mediat        ISSN: 1098-8823            Impact factor:   3.072


  11 in total

Review 1.  Cyclooxygenases and lipoxygenases in cancer.

Authors:  Claus Schneider; Ambra Pozzi
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

2.  TFEB, a master regulator of autophagy and biogenesis, unexpectedly promotes apoptosis in response to the cyclopentenone prostaglandin 15d-PGJ2.

Authors:  Chuan-Bin Yang; Jia Liu; Benjamin Chun-Kit Tong; Zi-Ying Wang; Zhou Zhu; Cheng-Fu Su; Sravan Gopalkrishnashetty Sreenivasmurthy; Jia-Xi Wu; Ashok Iyaswamy; Senthilkumar Krishnamoorthi; Shi-Ying Huang; King-Ho Cheung; Ju-Xian Song; Jie-Qiong Tan; Jia-Hong Lu; Min Li
Journal:  Acta Pharmacol Sin       Date:  2021-08-20       Impact factor: 6.150

Review 3.  15d-PGJ2 is a new hope for controlling tumor growth.

Authors:  Qingli Bie; Haixin Dong; Chengqiang Jin; Hao Zhang; Bin Zhang
Journal:  Am J Transl Res       Date:  2018-03-15       Impact factor: 4.060

4.  Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases.

Authors:  Ajit A Kulkarni; Collynn F Woeller; Thomas H Thatcher; Sesquile Ramon; Richard P Phipps; Patricia J Sime
Journal:  PPAR Res       Date:  2012-06-18       Impact factor: 4.964

5.  Tudor staphylococcal nuclease drives chemoresistance of non-small cell lung carcinoma cells by regulating S100A11.

Authors:  Anna Zagryazhskaya; Olga Surova; Nadeem S Akbar; Giulia Allavena; Katarina Gyuraszova; Irina B Zborovskaya; Elena M Tchevkina; Boris Zhivotovsky
Journal:  Oncotarget       Date:  2015-05-20

6.  15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss.

Authors:  Ki Rim Kim; Hyun Jeong Kim; Sun Kyoung Lee; Gwang Taek Ma; Kwang Kyun Park; Won Yoon Chung
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

7.  15-Deoxy-Δ12,14-prostaglandin J2 Induces Apoptosis in Ha-ras-transformed Human Breast Epithelial Cells by Targeting IκB kinase-NF-κB Signaling.

Authors:  Hye-Kyung Na; Hongkyung Yang; Young-Joon Surh
Journal:  J Cancer Prev       Date:  2020-06-30

8.  Methyl jasmonate enhances the radiation sensitivity of esophageal carcinoma cells by inhibiting the 11-ketoprostaglandin reductase activity of AKR1C3.

Authors:  Xiaoying Li; Xin Hong; Xianshu Gao; Xiaobin Gu; Wei Xiong; Jing Zhao; Hongliang Yu; Ming Cui; Mu Xie; Yun Bai; Shaoqian Sun
Journal:  Cancer Manag Res       Date:  2018-08-31       Impact factor: 3.989

9.  Transcription of liver X receptor is down-regulated by 15-deoxy-Δ(12,14)-prostaglandin J(2) through oxidative stress in human neutrophils.

Authors:  Gonzalo Alba; María Edith Reyes; Consuelo Santa-María; Remedios Ramírez; Isabel Geniz; Juan Jiménez; José Martín-Nieto; Elízabeth Pintado; Francisco Sobrino
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

10.  DP1 receptor signaling prevents the onset of intrinsic apoptosis in eosinophils and functions as a transcriptional modulator.

Authors:  Miriam Peinhaupt; David Roula; Anna Theiler; Miriam Sedej; Rudolf Schicho; Gunther Marsche; Eva M Sturm; Ian Sabroe; Marc E Rothenberg; Akos Heinemann
Journal:  J Leukoc Biol       Date:  2018-04-01       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.